News
-
EFPIA advocates for responsible AI use in medicine development
The European Federation of Pharmaceutical Industries and Associations (EFPIA) underlines the potential benefits of employing Artificial Intelligence (AI) in advancing patient care, fostering innovation, and benefiting society at large.
-Read more-
-
European Parliament approves EHDS
On 24 April 2024, the European Parliament endorsed the provisional agreement on the European Health Data Space (EHDS) reached between the Parliament and the Council.
-Read more-
-
In the literature: May 2024 highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
PhD and postdoc opportunities - May 2024
New calls with deadlines end May-early June
-Read more-
-
In silico trial predict phase 3 clinical trial result
Dr. Duruisseaux from the Hospice Civil de Lyon (France) prospectively replicated a three-year long phase 3 trial (FLAURA 2) with an in silico trial executed on 5000 virtual patients, in few weeks. Days before the official release of the phase 3 FLAURA 2 results, he posted the promising results of the in-silico prediction on X, formerly Twitter, which closely resembled the real-clinical trials, albeit at fraction of time and cost.
-Read more-
-
VPHi Best Poster Award 2024
All VPHi student members bringing a poster to the VPH2024 Conference will be automatically considered for the VPHi Best Poster Award that consists of a Certificate and a 350€ money prize.
-Read more-
